Rowena Schwartz, PharmD, BCOP, associate professor of pharmacy at the University of Cincinnati, joins Deborah Struth, MSN, RN, ONS research associate, to discuss the rapid emergence of biosimilar products on the market and how they’ll impact the treatment of cancer. Learn more about what biosimilars are, their approval processes, and the important things to know for practice.
To discuss the information in this episode with other oncology nurses, visit the ONS Communities.
To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org.
Listen on Apple Podcasts, Listen on Google Podcasts, Listen on Stitcher, Listen on Spotify, Listen on Amazon Music
Expand your knowledge by listening to the Oncology Nursing Podcast.View All Podcasts